LIAROZOLE, (-)-
UNII 17NYD2210B

Substance Identification & Data

This profile provides standardized clinical and technical data for Liarozole, (-)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 17NYD2210B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 171849-18-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
17NYD2210B
CAS Registry Number
171849-18-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIAROZOLE, (-)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C17H13ClN4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UGFHIPBXIWJXNA-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n1(C(c2cc3[nH]cnc3cc2)c4cc(Cl)ccc4)cncc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Liarozole, (-)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LIAROZOLE, (-)-

Systematic Nomenclature

1H-BENZIMIDAZOLE, 5-((3-CHLOROPHENYL)-1H-IMIDAZOL-1-YLMETHYL)-, (-)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record